BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17213815)

  • 1. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
    Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
    Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome.
    Seki Y; Suico MA; Uto A; Hisatsune A; Shuto T; Isohama Y; Kai H
    Cancer Res; 2002 Nov; 62(22):6579-86. PubMed ID: 12438253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic transformation by SEI-1 is associated with chromosomal instability.
    Tang DJ; Hu L; Xie D; Wu QL; Fang Y; Zeng Y; Sham JS; Guan XY
    Cancer Res; 2005 Aug; 65(15):6504-8. PubMed ID: 16061626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
    Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
    Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
    Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
    Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDCD4 inhibits the malignant phenotype of ovarian cancer cells.
    Wei ZT; Zhang X; Wang XY; Gao F; Zhou CJ; Zhu FL; Wang Q; Gao Q; Ma CH; Sun WS; Fu QZ; Chen YH; Zhang LN
    Cancer Sci; 2009 Aug; 100(8):1408-13. PubMed ID: 19493270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression.
    Miyanishi M; Mandai M; Matsumura N; Yamaguchi K; Hamanishi J; Higuchi T; Takakura K; Fujii S
    Oncol Rep; 2007 Feb; 17(2):329-33. PubMed ID: 17203169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis.
    Keshava N; Gubba S; Tekmal RR
    J Soc Gynecol Investig; 1999; 6(1):41-9. PubMed ID: 10065425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties.
    Miyazaki Y; Sun X; Uchida H; Zhang J; Nimer S
    Oncogene; 1996 Oct; 13(8):1721-9. PubMed ID: 8895518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells.
    Davis JN; Rogers D; Adams L; Yong T; Jung JS; Cheng B; Fennell K; Borazanci E; Moustafa YW; Sun A; Shi R; Glass J; Mathis JM; Williams BJ; Meyers S
    J Cell Physiol; 2010 Nov; 225(3):875-87. PubMed ID: 20607802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplastic transformation and tumorigenesis associated with overexpression of IMUP-1 and IMUP-2 genes in cultured NIH/3T3 mouse fibroblasts.
    Ryoo ZY; Jung BK; Lee SR; Kim MO; Kim SH; Kim HJ; Ahn JY; Lee TH; Cho YH; Park JH; Kim JK
    Biochem Biophys Res Commun; 2006 Oct; 349(3):995-1002. PubMed ID: 16962562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis.
    Hsu SH; Hsieh-Li HM; Huang HY; Huang PH; Li H
    Cancer Res; 2005 May; 65(10):4041-50. PubMed ID: 15899793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
    Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
    Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
    Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
    Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
    Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
    Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
    Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.
    Popadiuk CM; Xiong J; Wells MG; Andrews PG; Dankwa K; Hirasawa K; Lake BB; Kao KR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2216-23. PubMed ID: 16609037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.